Need for over-the-counter birth control ‘has never been greater’

• ‘The next important decision is going to be what price these pills will cost’

CHICAGO --- Women’s reproductive health experts from Northwestern Medicine are available today for interviews with media on the U.S. Food and Drug Administration’s (FDA) approval of the Opill (norgestrel) tablet, the first daily oral contraceptive approved for use in the U.S. without a prescription.

The experts: 

Dr. Lauren Streicher, clinical professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine.

Dr. Melissa Simon, vice chair for research in the department of obstetrics and gynecology and professor of obstetrics and gynecology, preventive medicine and medical social sciences at Feinberg and a Northwestern Medicine physician.

To schedule an interview with either expert, contact Kristin Samuelson at ksamuelson@northwestern.edu.

Quotes from Dr. Streicher:

“With new restrictions making access to abortion for unintended pregnancies non-existent in much of the country, the need for easy access to reliable contraception has never been greater.

“Barriers to obtaining contraception, such as the prescription requirement, contribute to our nation’s sky-high unintentional pregnancy rate. Getting a prescription is a huge burden to many women who have no regular physician, no insurance and a job that doesn’t allow the luxury of taking an afternoon off to go to see a doctor. The college student without a gynecologist (and without a car) doesn’t have it any easier. Not to mention, many insurance companies only release one month of pills at a time. It’s easy to understand how a prescription can lapse. 

“Opponents express concern that high-risk women are likely to take birth control pills, which will lead to an increase in serious side effects such as blood clots and heart attacks. The average woman is more than capable of self-screening and determining if taking pills would be dangerous or inappropriate. No woman wants to have a medical complication. If someone has a medical issue such that she’s not a candidate for hormonal contraception, it is not dissimilar to a man with kidney failure who is informed that over-the-counter painkillers are not safe.

“Most women spend the majority of their reproductive years trying to avoid becoming pregnant. The solution to lowering our country’s high unintended pregnancy rate is not going to be completely solved by increasing access to contraception, but it’s a really good start, and I’m all for it.” 

Quotes from Dr. Simon:

“This is a monumental decision to finally have over-the-counter approval for an oral contraceptive. The FDA should be applauded for aligning contraceptive access with the science.

“Over-the-counter birth control is available in more than 100 countries, so the U.S. is substantially behind in availing safe, effective ways such as this oral contraceptive pill to individuals who are trying to avoid pregnancy and plan their families.

“The next important decision is going to be what price these pills will cost. This decision on cost is critical to ensuring equitable access for all persons who will want to use and will benefit from this pill. If the price point is set too high, this will prohibit those from lower socioeconomic backgrounds from access. This is especially important in states that have near total or total abortion bans — where access to and use of contraception to prevent unintended pregnancy is critical."